Hanseatic Management Services’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Hanseatic Management Services’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-4,247	Closed	-$207K	–	500
2017 Q4	$207K	Sell	4,247 -1,170	-22%	-$59.2K	0.21%	122
2017 Q3	$293K	Sell	5,417 -17,383	-76%	-$1.02M	0.33%	93
2017 Q2	$1.28M	Buy	22,800 +70	+0.3%	+$2.8K	0.65%	55
2017 Q1	$891K	Buy	+22,730	New	+$724K	0.49%	78

Other funds holding PTLA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

KCM

Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Hanseatic Management Services's PTLA Position: Q1 2018 in Review

Hanseatic Management Services sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2018, closing a stake of 4,247 shares — an estimated $207K sold.

Hanseatic Management Services first reported a position in PTLA in Q1 2017 and held it in 4 quarters. The position peaked at $1.28M in Q2 2017. 180 funds tracked by Wall St. Rank hold PTLA as of Q1 2018.

Hanseatic Management Services reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
Hanseatic Management Services sold 4,247 Portola Pharmaceuticals, Inc. shares in Q1 2018, an estimated $207K.
Hanseatic Management Services first reported a position in Portola Pharmaceuticals, Inc. in Q1 2017 and held it in 4 quarters.
Hanseatic Management Services's Portola Pharmaceuticals, Inc. position peaked at $1.28M in Q2 2017.
180 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2018.

Based on Hanseatic Management Services's 13F filing for Q1 2018, filed 2 May 2018.